Washington Post Live(@PostLive) 's Twitter Profile Photo

.Joseph Betancourt says, “If you have two patients, all things equal about them except the color of their skin, who present to an emergency room… with chest pain… minorities are significantly less likely to be referred for cardiac catheterization, angioplasty, bypass surgery.”

account_circle
PharmaShots - Incisive news in 3 shots(@Pharmashot) 's Twitter Profile Photo

argenx to Initiates Second Cohort of P-II Study (ARDA) Results of Empasiprubart for Multifocal Motor Neuropathy
argenx
pharmashots.com/15541/argenx-t…

argenx to Initiates Second Cohort of P-II Study (ARDA) Results of Empasiprubart for Multifocal Motor Neuropathy 
@argenxglobal #clinicaltrials 
pharmashots.com/15541/argenx-t…
account_circle
SCWD(@SCWDnews) 's Twitter Profile Photo

💪🩺 Hand grip strength: A game-changer in cachexia ?

SCWD president; Stefan Anker discusses the value of hand grip strength in cachexia clinical trials

account_circle
Oncology FACETS(@OncologyFACETS) 's Twitter Profile Photo

“Introduction to Becoming a Clinical Trialist in Gynecologic Oncology | Part 1: Clinical Research Process,” is now available! Here's a video featuring one of its Steering Committee champions, Dr. Premal Thaker. Go to oncologyfacets.com/clinical-resea… to access the module.

account_circle
TZ Medical(@medical_tz) 's Twitter Profile Photo

Optimal Radial Hemostasis with no syringes or leaking bubbles. ROC Band offers consistent pressure, total visibility, and ulnar access for patent hemostasis. Request a Free Demo & try ROC Band in your lab today!

account_circle
Immunolight LLC(@immunolight) 's Twitter Profile Photo

It just keeps getting better at Immunolight! Visit our website (immunolight.com) to see how our mission of Illumination, Innovation, and Transformation technology is growing!

It just keeps getting better at Immunolight! Visit our website (immunolight.com) to see how our mission of Illumination, Innovation, and Transformation technology is growing! #immunolight #illumination #innovation #transformation #clinicaltrials #clinicalresearch
account_circle
SeaStarMedical(@SeaStarMedical) 's Twitter Profile Photo

PRESS RELEASE: First Patient Enrolled in SeaStar Medical’s Pivotal Clinical Trial with the Selective Cytopheretic Device in Adults with Acute Kidney Injury

Read the full release here: investors.seastarmedical.com/news/news-deta…

$ICU

account_circle
Clinvest Research(@Clinvest417) 's Twitter Profile Photo

June 21 is Shades for Migraine Day! Clinvest Research is joining the challenge in support of 1 billion worldwide suffering from migraine attacks. We are passionate about discovering new solutions and being a part of a brighter future. 💜

June 21 is Shades for Migraine Day! Clinvest Research is joining the #ShadesForMigraine challenge in support of 1 billion worldwide suffering from migraine attacks. We are passionate about discovering new solutions and being a part of a brighter future. 💜

#mham  #clinicaltrials
account_circle
Nature Medicine(@NatureMedicine) 's Twitter Profile Photo

⚡️Our June issue is out!⚡️This month includes on oncolytic virotherapy in , on antisense oligonucleotide for and a study on a polygenic risk score for , as well as news, opinions and much more! nature.com/nm/volumes/29/…

⚡️Our June issue is out!⚡️This month includes #ClinicalTrials on oncolytic virotherapy in #Glioblastoma , on antisense oligonucleotide for #Alzheimers and a study on a polygenic risk score for #Preeclampsia, as well as news, opinions and much more! nature.com/nm/volumes/29/…
account_circle
EU Medicines Agency(@EMA_News) 's Twitter Profile Photo

The Accelerating Clinical Trials in the EU initiative, or ACT EU, is today organising the kick-off workshop for a new multi-stakeholder platform to create a better environment for clinical trials in the EU.
👉ema.europa.eu/en/news/act-eu…

The Accelerating Clinical Trials in the EU initiative, or ACT EU, is today organising the kick-off workshop for a new multi-stakeholder platform to create a better environment for clinical trials in the EU.
👉ema.europa.eu/en/news/act-eu…

#ACTEU #ClinicalTrials
account_circle
Rare Disease Clinical Trial Network, Ireland(@rare_trial) 's Twitter Profile Photo

Do you have lived experience of ?

Would you like to share your insights and experiences to help prioritise and shape for rare diseases in Ireland?

If so, we'd love to hear from you!👇

ClinicalTrials

Do you have lived experience of #RareDisease?

Would you like to share your insights and experiences to help prioritise and shape #clinicaltrials for rare diseases in Ireland?

If so, we'd love to hear from you!👇

#PPI #PatientandPublicInvolvement #RareDiseaseClinicalTrials
account_circle
The Good Clinical Trials Collaborative(@goodtrials) 's Twitter Profile Photo

🔊 The second edition of the newsletter is out now!

Find out what the Collaborative has been up to these past few months and what's coming down the pipe!

Read and subscribe here 👇



lnkd.in/engwUQ7s

🔊 The second edition of the #InsideGoodTrials newsletter is out now!

Find out what the Collaborative has been up to these past few months and what's coming down the pipe!

Read and subscribe here 👇

#goodtrials #clinicaltrials #RCTs #globalhealth

lnkd.in/engwUQ7s
account_circle
Big Al's Exotics(@big_Alssexotics) 's Twitter Profile Photo

MindBio Therapeutics will be at Multidisciplinary Association for Psychedelic Studies (MAPS)Psychedelic Science 2023 in Denver this week, talking about and our Phase I & II Clinical Trials. Come chat with us.

MindBio Therapeutics will be at Multidisciplinary Association for Psychedelic Studies (MAPS)Psychedelic Science 2023 in Denver this week, talking about #lsd #microdosing and our Phase I & II Clinical Trials. Come chat with us.

#science #clinicaltrials
account_circle
Kevin C(@Aquahoya) 's Twitter Profile Photo

Shankwoods Additionally, most of these early stage like $GSTC can get valued so highly is because 1) Partnerships/licenisng, 2) scarcity and competition, 3) potential blockbuster drug, 4) intellectual property, and 5) future revenue potential

account_circle